Clinical Trials
33 trialsHigh-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
Sun Yat-sen University
Exo-LCR
Centre Oscar Lambret
Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
H. Lee Moffitt Cancer Center and Research Institute
Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors
Memorial Sloan Kettering Cancer Center
Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HIT
Institut Curie
Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Beijing Tiantan Hospital
Ipilimumab and Nivolumab in Leptomeningeal Metastases
Massachusetts General Hospital
DEBBRAH
MedSIR
Intrathecal Pemetrexed for Leptomeningeal Metastasis
The First Hospital of Jilin University
ORBITAL
Intergroupe Francophone de Cancerologie Thoracique
SCNSL1
IRCCS San Raffaele
Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer
Columbia University
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases
Memorial Sloan Kettering Cancer Center
Safety Study of Afatinib for Brain Cancer
Saint John's Cancer Institute
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Northwestern University
Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases
The Netherlands Cancer Institute
A Pilot Study of Bevacizumab for Neoplastic Meningitis
M.D. Anderson Cancer Center
Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)
Dartmouth-Hitchcock Medical Center
Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors
The First Hospital of Jilin University
Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors
The First Hospital of Jilin University
DEPOSEIN
Centre Oscar Lambret
Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer
The First Hospital of Jilin University
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
University of Washington
Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
University of California, San Francisco
Epothilone B in Treating Patients With CNS Metastases From Breast Cancer
Case Comprehensive Cancer Center
Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis
National Taiwan University Hospital
Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
Duke University
Melphalan in Patients With Neoplastic Meningitis
Duke University
LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases
Duke University
Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
Duke University
Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain
NYU Langone Health
PBTC-019
Baylor College of Medicine